Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US
Mycoses, 06/14/2011
Clinical Article
Graham LVC et al. – Oral terbinafine has been approved for onychomycosis for 20 years in Europe and 15 years in the United States. Terbinafine remains a superior treatment for dermatophyte infections because of its safety, fungicidal profile, once daily dosing, and its ability to penetrate the stratum corneum.



